Amanda Rose advises life sciences and technology companies with respect to corporate finance, SEC reporting and governance matters. Amanda has represented issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, follow-on and secondary offerings, at-the-market offerings, PIPEs and preferred stock and debt financings. She also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters, including corporate governance best practices, Exchange Act reporting obligations and stock exchange requirements. Chambers USA ranks Amanda as a top capital markets lawyer, with clients saying, "Amanda stands out as an exceptional young attorney with great judgment, poise, 24/7 availability and extreme attention to detail."

Prior to joining Fenwick & West, Amanda was an associate in the Corporate Group at Dorsey & Whitney LLP.

Amanda received her J.D., magna cum laude, from the Seattle University School of Law in 2009, where she was Associate Editor for the Seattle University Law Review. She earned her B.A., cum laude, in Political Science and Communication from the University of Washington in 2006.

Amanda is a member of the State Bar of Washington.